EVT0010938_-_Cost_Sheet.updated.pdf

This cost sheet is associated with an RFP issued by the Kansas Department of Health and Environment for Next-generation Sequencing (NGS) analysis of dried blood spots for Lysosomal Disorders screening. The scope of work encompasses NGS analysis of six genetic conditions: IDUA gene (Mucopolysaccharidosis Type I), IDS gene (Mucopolysaccharidosis Type II), GAA gene (Pompe disease), GALC gene (Krabbe disease), ARSA gene (Metachromatic Leukodystrophy), and DMD gene (Duchenne Muscular Dystrophy). The vendor is expected to process approximately 250 newborn screening specimens annually. All NGS results must be delivered via official vendor-letterhead reports through email, fax, or online portal within fourteen business days of specimen receipt. Proposals were due October 13, 2026 at 2:00 p.m. CST, with questions due by September 17, 2026. The contract term is three years from award through December 31, 2029, with options to renew for two additional twelve-month periods.

Vendors must provide individual pricing per genetic condition screened as well as bulk pricing at various volume levels, with all prices fixed throughout the contract period. Delivery and all associated shipping, handling, and insurance costs are F.O.B. inside the Kansas Health and Environment Laboratories in Topeka, Kansas. Payment terms are Net 30 days via electronic funds transfer or State Procurement Card without additional charges. Vendors claiming applicable preferences under Kansas's Certified Business or Disabled Veteran Owned Business programs must provide supporting documentation. All bidders must obtain current Tax Clearance Certificates from the Kansas Department of Revenue, complete mandatory State of Kansas vendor registration, and submit Boycott of Israel, Sexual Harassment, and Immigration Reform and Control certifications. A Procurement Negotiation Committee will conduct evaluation and reserves the right to negotiate with selected bidders.